These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8357185)

  • 41. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.
    Protti MP; Manfredi AA; Straub C; Wu XD; Howard JF; Conti-Tronconi BM
    J Immunol; 1990 Mar; 144(5):1711-20. PubMed ID: 1968487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis.
    Sato T; Ishigaki Y; Komiya T; Tsuda H
    Ann N Y Acad Sci; 1988; 540():554-6. PubMed ID: 3061349
    [No Abstract]   [Full Text] [Related]  

  • 45. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-cell clones specific to acetylcholine receptor, its subunits, and peptides.
    Fujii Y; Lindstrom J
    Ann N Y Acad Sci; 1988; 540():357-9. PubMed ID: 3264675
    [No Abstract]   [Full Text] [Related]  

  • 47. Monoclonal antibodies as probes for acetylcholine receptor epitopes in thymuses and thymic epithelial tumors of patients with myasthenia gravis and nonmyasthenic controls.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Ann N Y Acad Sci; 1988; 540():508-10. PubMed ID: 2462825
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
    Katz-Levy Y; Kirshner SL; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7000-4. PubMed ID: 7688469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up study of relapse in symptoms and reelevation of acetylcholine receptor antibody titers in patients with myasthenia gravis.
    Komiya T; Sato T
    Ann N Y Acad Sci; 1988; 540():605-7. PubMed ID: 3207287
    [No Abstract]   [Full Text] [Related]  

  • 50. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of acetylcholine receptor antibody in relatives of myasthenic patients.
    Walker GL; Nicholson LV; Mastaglia FL
    Lancet; 1980 Apr; 1(8171):778-9. PubMed ID: 6103204
    [No Abstract]   [Full Text] [Related]  

  • 52. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
    Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Nicotinic cholinergic receptor and myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Aug; 16(4):250-3. PubMed ID: 6315322
    [No Abstract]   [Full Text] [Related]  

  • 55. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracorporeal whole blood immuno-adsorption of passively transferred myasthenia gravis rabbits by cellulose-tryptophan column.
    Li XH; Cheng Y; Yang L; Wang SQ; Yu YT
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Aug; 38(4):186-91. PubMed ID: 20380507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH; Barchan D; Souroujon MC; Fuchs S
    J Immunol; 2000 Oct; 165(7):3599-605. PubMed ID: 11034361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies against the acetylcholine receptor also in nonmyasthenic autoimmune disease.
    Sundewall AC; Lefvert K
    Ann N Y Acad Sci; 1988; 540():525-7. PubMed ID: 3207283
    [No Abstract]   [Full Text] [Related]  

  • 59. Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.
    Jung HH; Yi HJ; Lee SK; Lee JY; Jung HJ; Yang ST; Eu YJ; Im SH; Kim JI
    Biochemistry; 2007 Dec; 46(51):14987-95. PubMed ID: 18052043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
    Gomez CM; Richman DP
    J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.